Fire disrupts production at GSK Pharma’s contract manufacturing site

GlaxoSmithKline Pharmaceuticals (GSK Pharma) on Friday informed the stock exchanges that a fire had occurred at one of its contract manufacturing facilities, causing a temporary disruption in production at the site.

While the exact location of the facility and the extent of the damage were not disclosed, the company said in a regulatory filing to the BSE and the National Stock Exchange (NSE) that it is currently assessing the impact of the incident and is working closely with the site to resume operations at the earliest.

“We are assessing the impact and working closely with the site to expedite resumption of operations,” the company said in the exchange filing.

GSK Pharma is the Indian subsidiary of the UK-headquartered pharmaceutical giant GlaxoSmithKline, with a portfolio spanning prescription medicines and vaccines in India.

Related Posts

GLP-1 injections recalled across the US over sterility concerns

A nationwide recall of compounded tirzepatide injections in the United States has raised fresh concerns about the safety of weight-loss medicines. The recall, initiated by Apothecary Pharma LLC over concerns…

Govt allows third-party agencies to conduct departmental inspections

Bengaluru: The government has directed various departments to engage authorised third-party agencies to carry out scheduled inspections, audits and certification activities in areas where staff shortages have delayed regulatory checks.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

GLP-1 injections recalled across the US over sterility concerns

GLP-1 injections recalled across the US over sterility concerns

Govt allows third-party agencies to conduct departmental inspections

Govt allows third-party agencies to conduct departmental inspections

Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires